Oscar Health Inc. Class A (OSCR)
NYSE: OSCRHealth CareMedical SpecialitiesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
After hours: 33.03 -0.21%
OSCR stock chart
Technical analysisKey statistics
All statistics- Market cap
- $10.22B
- P/E (TTM)
- 25.66
- Forward P/E
- 15.29
- EPS (TTM)
- $1.29
- Dividend yield
- None
- 52-week range
- 10.69 – 34.48
- Day range
- 32.25 – 33.42
- Volume / Avg
- 4.12M / 5.18M
- Beta
- —
- Shares outstanding
- 273.47M
- Next earnings
- Nov 5, 2026
52-week range
OSCR stock today
Oscar Health (OSCR) closed at $33.10 on Oct 8, up 0.58% (+$0.19), versus the S&P 500's 0.47% decline. Shares are 4.0% below their 52-week high of $34.48, set on Sep 14, 2026 and 209.6% above the 52-week low of $10.69, near the top of the past year's range. OSCR is up 129.0% year to date, outperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has gained 46.5%.
At 25.7x trailing earnings, Oscar Health trades in line with the peer-group median of 24.7x. Its forward P/E of 15.3x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. Oscar Health's next earnings report is expected on Nov 5, 2026.
Summary generated from market data by MetaCap's automated system. Methodology
About Oscar Health
Company profileOscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets.
- Sector
- Health Care
- Industry
- Medical Specialities
- CEO
- Mr. Mark Thomas Bertolini
- Headquarters
- New York, NY
- Employees
- 2,305
- IPO year
- 2021
- Website
- hioscar.com
Financial highlights
Full financialsIn fiscal 2025, Oscar Health generated $11.70 billion in revenue, up 27.5% from fiscal 2024, its 5th consecutive year of revenue growth. Oscar Health reported a net loss of $443.2 million, compared with net income of $25.4 million a year earlier. Operating margin was -3.4%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $11.70B | $9.18B | $5.86B | $3.96B | $1.84B |
| Growth | +27.50% | +56.54% | +47.92% | +115.57% | +297.30% |
| Net income | $-443.15M | $25.43M | $-270.73M | $-606.27M | $-572.61M |
| EPS (diluted) | $-1.69 | $0.10 | $-1.22 | $-2.85 | $-3.20 |
Analyst forecast
ForecastConsensus (11 analysts)
hold
Avg. price target
$35.40+6.95%
- Strong buy 3
- Buy 0
- Hold 7
- Sell 0
- Strong sell 1
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Next report
- Nov 5, 2026
- EPS estimate
- $-0.11
- Last reported (Q2 2026)
- Aug 7, 2026
- EPS actual vs est.
- $1.10 vs —
OSCR news
All OSCR newsOscar Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MOHMolina Healthcare Inc | 195.76 | +0.48% | $10.22B | vs OSCR |
| HSICHenry Schein Inc. | 84.63 | +1.16% | $9.43B | vs OSCR |
| CAICaris Life Sciences Inc. | 27.50 | +1.48% | $7.77B | vs OSCR |
| GRALGRAIL Inc. | 132.61 | -0.22% | $5.92B | vs OSCR |
| RDNTRadNet Inc. | 68.21 | -0.58% | $5.37B | vs OSCR |
| CONConcentra Group Holdings Parent Inc. | 36.61 | +0.58% | $4.67B | vs OSCR |
| BLLNBillionToOne Inc. Class A | 95.41 | -0.36% | $4.50B | vs OSCR |
| VCYTVeracyte Inc. | 43.60 | +1.02% | $3.51B | vs OSCR |
Indexes, lists and sector
Oscar Health stock FAQ
What is Oscar Health's stock price today?
OSCR last traded at $33.10 as of Oct 8, 4:00 PM EDT, up 0.58% on the day. Prices are delayed at least 15 minutes.
When is Oscar Health's next earnings date?
Oscar Health is expected to report earnings on Thursday, November 5, 2026. Analysts expect EPS of $-0.11.
What is OSCR's P/E ratio?
OSCR trades at a trailing P/E ratio of 25.66 and a forward P/E of 15.29, compared with a median of 24.7 for its closest peers.
Who is Oscar Health's CEO?
Mr. Mark Thomas Bertolini is the chief executive officer of Oscar Health Inc. Class A, which has about 2,305 employees.
What is the OSCR 52-week high?
The 52-week high for OSCR is $34.48 and the 52-week low is $10.69. The stock is currently 4.0% below its high.